DREAM-ICD-II研究:二级预防ICD后驾驶限制可缩短至3个月
该回顾性多中心研究纳入2016至2020年加拿大3家三级中心连续新植入二级预防ICD的721例患者,中位随访760天。结果显示适当治疗导致的突发心脏失能发生率在前3个月最高后显著下降,支持将驾驶限制从6个月缩短至3个月。
要点
- 二级预防ICD后前3个月复发性室性心律失常风险最高,之后显著下降。
- 适当治疗导致突发心脏失能的累积发生率前90天为1.8%,91-180天降至0.4%。
- 将驾驶限制缩短至3个月似乎安全,现有6个月限制应重新考虑。
核心结论
- 当代二级预防ICD受者中适当治疗导致突发心脏失能的发生率远低于既往报告,且前3个月后显著下降。
- 将驾驶限制缩短至3个月似乎安全,仍执行6个月限制的国家应考虑修订指南。
研究设计与样本
- 回顾性研究,纳入2016至2020年加拿大3家三级中心连续新植入二级预防ICD的721例患者,中位随访760天(324,1190天)。
主要发现
- 复发性室性心律失常风险在植入后前3个月最高(34.4%),3-6个月为10.6%,6-12个月为11.7%。
- 每100患者-天的适当治疗发生率在90天时为0.48(95%CI 0.35-0.64),180天时为0.28(95%CI 0.17-0.45),181-365天为0.21(95%CI 0.13-0.33)(P<0.001)。
- 导致突发心脏失能的心律失常性晕厥累积发生率在植入后前90天为1.8%,91-180天降至0.4%(P<0.001)。
临床怎么用
- 对于二级预防ICD植入患者,可考虑将私人驾驶限制缩短至3个月,而非现行6个月。
- 临床决策时应告知患者前3个月心律失常风险最高,需加强监测与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Regulatory authorities of most industrialized countries recommend 6 months of private driving restriction after implantation of a secondary prevention implantable cardioverter-defibrillator (ICD). These driving restrictions result in significant inconvenience and social implications. This study aimed to assess the incidence rate of appropriate device therapies in contemporary recipients of a secondary prevention ICD. METHODS: This retrospective study at 3 Canadian tertiary care centers enrolled consecutive patients with new secondary prevention ICD implants between 2016 and 2020. RESULTS: For a median of 760 days (324, 1190 days), 721 patients were followed up. The risk of recurrent ventricular arrhythmia was highest during the first 3 months after device insertion (34.4%) and decreased over time (10.6% between 3 and 6 months, 11.7% between 6 and 12 months). The corresponding incidence rate per 100 patient-days was 0.48 (95% CI, 0.35-0.64) at 90 days, 0.28 (95% CI, 0.17-0.45) at 180 days, and 0.21 (95% CI, 0.13-0.33) between 181 and 365 days after ICD insertion (P<0.001). The cumulative incidence of arrhythmic syncope resulting in sudden cardiac incapacitation was 1.8% within the first 90 days and subsequently dropped to 0.4% between 91 and 180 days (P<0.001) after ICD insertion. CONCLUSIONS: The incidence rate of appropriate therapies resulting in sudden cardiac incapacitation in contemporary recipients of a secondary prevention ICD is much lower than previously reported and declines significantly after the first 3 months. Lowering driving restrictions to 3 months after the index cardiac event seems safe, and revision of existing guidelines should be considered in countries still adhering to a 6-month period. Existing restrictions for private driving after implantation of a secondary prevention ICD should be reconsidered.
引用
- Steinberg C, Dognin N, Sodhi A, et al. DREAM-ICD-II Study. Circulation. 2021. PMID: 34913361. doi:10.1161/CIRCULATIONAHA.121.056471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。